Literature DB >> 27123691

Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience.

Julita Gil Cuesta1, Preben Aavitsland, Hélène Englund, Ólafur Gudlaugsson, Siri Helene Hauge, Outi Lyytikäinen, Guðrún Sigmundsdóttir, Anders Tegnell, Mikko Virtanen, Tyra Grove Krause.   

Abstract

During the 2009/10 influenza A(H1N1)pdm09 pandemic, the five Nordic countries adopted different approaches to pandemic vaccination. We compared pandemic vaccination strategies and severe influenza outcomes, in seasons 2009/10 and 2010/11 in these countries with similar influenza surveillance systems. We calculated the cumulative pandemic vaccination coverage in 2009/10 and cumulative incidence rates of laboratory confirmed A(H1N1)pdm09 infections, intensive care unit (ICU) admissions and deaths in 2009/10 and 2010/11. We estimated incidence risk ratios (IRR) in a Poisson regression model to compare those indicators between Denmark and the other countries. The vaccination coverage was lower in Denmark (6.1%) compared with Finland (48.2%), Iceland (44.1%), Norway (41.3%) and Sweden (60.0%). In 2009/10 Denmark had a similar cumulative incidence of A(H1N1)pdm09 ICU admissions and deaths compared with the other countries. In 2010/11 Denmark had a significantly higher cumulative incidence of A(H1N1)pdm09 ICU admissions (IRR: 2.4; 95% confidence interval (CI): 1.9-3.0) and deaths (IRR: 8.3; 95% CI: 5.1-13.5). Compared with Denmark, the other countries had higher pandemic vaccination coverage and experienced less A(H1N1)pdm09-related severe outcomes in 2010/11. Pandemic vaccination may have had an impact on severe influenza outcomes in the post-pandemic season. Surveillance of severe outcomes may be used to compare the impact of influenza between seasons and support different vaccination strategies.

Entities:  

Keywords:  Pandemics; influenza A(H1N1)pdm09; influenza A(H3N2); influenza B virus; influenza virus; intensive care units; vaccines and immunisation

Mesh:

Substances:

Year:  2016        PMID: 27123691     DOI: 10.2807/1560-7917.ES.2016.21.16.30208

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  6 in total

Review 1.  Narcolepsy Associated with Pandemrix Vaccine.

Authors:  Tomi Sarkanen; Anniina Alakuijala; Ilkka Julkunen; Markku Partinen
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-01       Impact factor: 5.081

Review 2.  Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome.

Authors:  Steven Nye; Richard J Whitley; Michele Kong
Journal:  Front Pediatr       Date:  2016-11-24       Impact factor: 3.418

3.  Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.

Authors:  Jennifer E Isenor; Beth A O'Reilly; Susan K Bowles
Journal:  BMC Public Health       Date:  2018-06-26       Impact factor: 3.295

4.  Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews.

Authors:  Lene Kristine Juvet; Anna Hayman Robertson; Ida Laake; Siri Mjaaland; Lill Trogstad
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

5.  Analysis of multi-level spatial data reveals strong synchrony in seasonal influenza epidemics across Norway, Sweden, and Denmark.

Authors:  Sinead E Morris; Birgitte Freiesleben de Blasio; Cécile Viboud; Amy Wesolowski; Ottar N Bjørnstad; Bryan T Grenfell
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

6.  Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study.

Authors:  Paz L D Ruiz; German Tapia; Inger J Bakken; Siri E Håberg; Olav Hungnes; Hanne L Gulseth; Lars C Stene
Journal:  Diabetologia       Date:  2018-06-22       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.